X. Mariette

Annals of the Rheumatic Diseases · 2002–2020

A researcher in the Science corpus: 18 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from X. Mariette's perspective

Ordered by how strongly the researchers X. Mariette trusts endorse each paper. Same corpus, a different order for every researcher.

1. A Coefficient of Agreement for Nominal Scales
2. Research Electronic Data Capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support (Journal of Biomedical Informatics)
3. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit.
4. A comparison of two time intervals for test-retest reliability of health status instruments. (Journal of Clinical Epidemiology)
5. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews (Cochrane Database of Systematic Reviews)
6. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. (Blood)
7. Classification Criteria for Systemic Sclerosis: An ACR-EULAR Collaborative Initiative (Arthritis & Rheumatism)
8. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (The Lancet)
9. Treating rheumatoid arthritis to target: recommendations of an international task force (Annals of the Rheumatic Diseases)
10. Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus (Arthritis & Rheumatism)

Their papers

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020) — 2,212 citations
• Immune-related adverse events of checkpoint inhibitors (2020) — 992 citations
• Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. (2020) — 716 citations
• EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies (2019) — 614 citations
• 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus (2019) — 3,045 citations
• Primary Sjögren's Syndrome (2018) — 892 citations
• Sjögren syndrome (2016) — 922 citations
• 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome (2016) — 1,045 citations
• 2016 ACR-EULAR Classification Criteria for primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts (2016) — 2,294 citations
• Treat-to-target in systemic lupus erythematosus: recommendations from an international task force (2014) — 688 citations
• FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries (2014) — 609 citations
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update (2013) — 1,725 citations
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (2010) — 2,684 citations
• Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. (2009) — 665 citations
• EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome (2009) — 932 citations
• Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. (2006) — 619 citations
• The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome (2003) — 607 citations
• Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. (2002) — 944 citations